• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BIT

BIOTRON LIMITED - News & Media

20.0% ! 0.2¢
Market Cap $2.654M  !
Healthcare Biotechnology
Add to My Watchlist

Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the... Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the research, development, and commercialization of drugs targeting significant viral diseases with unmet medical need. The Company has BIT225 in clinical development for HIV-1 and COVID-19, and additional preclinical programs including Hepatitis B Virus (HBV). In addition, the Company has several early-stage programs designing drugs that target a class of virus protein known as viroporins, which have a key role in the virus life cycle of a range of viruses, such as Coronavirus, Dengue, Ebola, Middle East Respiratory virus, Influenza and Zika viruses. Its proprietary primary bacterial cell-based screening platform enables rapid screening of target viroporin proteins. Its lead compound, BIT225, is in Phase II development for the treatment of HIV-1. The Company also has a portfolio of preclinical antiviral programs.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Wrong button: Biotron explains to ASX why possible bankruptcy wasn't price sensitive

It wasn't just Kalina Power getting told off by Compliance on Tuesday – Biotron also had to run the gauntlet.

04 Mar 2025 14:23 (AEDT)

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Biotron (ASX:BIT) has angered shareholders on HotCopper on Friday as the results of its latest COVID-facing trial come up dusty.

06 Sep 2024 13:04 (AEST)

Biotron jumps over 14% on latest HIV Phase 2 results; liquidity notably boosted

Shares in otherwise thinly traded healthcare microcap Biotron Limited (ASX:BIT) jumped 14.6% on Wednesday following trial results.

19 Jun 2024 12:35 (AEST)

Biotron (ASX:BIT) kicks off phase II COVID-19 clinical trial in Thailand

Biotron (ASX:BIT) has kicked off a phase II trial of its lead antiviral drug, BIT225, to treat COVID-19 within three days of the onset of symptoms over seven days of treatment.

04 May 2023 12:32 (AEST)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.2¢ 		Change
-0.001(20.0%) 		Mkt cap ! $2.654M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $2.28K 913.3K

Buyers (Bids)

No. Vol. Price($)
44 34518629 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 15608554 19
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
Last
0.3¢ 		  Change
-0.001 ( 0.00 %)
Open High Low Volume
0.3¢ 0.3¢ 0.3¢ 6000
Last updated 14.43pm 30/07/2025 ?
BIT (ASX) Chart

Top Stories

Ionic Rare Earths falls -7% as momentum slips on vague production update

Ionic Rare Earths (ASX:IXR) @ a well-known and much-loved rare earths darling on something of a comeback run lately @ has slipped -7%, presumably as the market digests what a vague update released on Wednesday actually means. According to the company, @urgent supply requests from US, European and...
Neurizon inks $1.5M loan against R&D Tax Rebate Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
ASX Market Close: Index rebounds as investors buoyant | July 30, 2025 The ASX200 rebounded today and was in the green heading into the close. Investors were buoyant in response to positive inflation data that increased the odds of an interest rate cut in August.Staples, Real Estate and Discretionary were the strongest performing sectors. Utilities and IT were a dra...
Haranga jumps +7% on Lincoln acquisition Haranga Resources (ASX:HAR) has spiked in intra-day trade after closing the acquisition of the Lincoln Gold Project in California.The Lincoln Project traverses 322 hectares and covers a strike length of the Mother Lode with 5.8km between Sutter Creek and Amador City. It boasts a gold resource of ...
HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic Let’s check in with what HotCopper users are closely watching at lunchtime. Given that we’re basically on the deadline before companies get a scolding if they don’t report updates, on Wednesday, the ASX announcements list is basically one big wall o...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.